Current Pharmaceutical Design
Title: Editorial [Hot Topic: Pharmaceutical and Cellular Strategies of Recent Advances in Immunotherapy (Executive Editors: George Tuszynski and Mahesh Sharma)]
Volume: 15 Issue: 17
Author(s): George Tuszynski and Mahesh Sharma
Affiliation:
Export Options
About this article
Cite this article as:
Tuszynski George and Sharma Mahesh, Editorial [Hot Topic: Pharmaceutical and Cellular Strategies of Recent Advances in Immunotherapy (Executive Editors: George Tuszynski and Mahesh Sharma)], Current Pharmaceutical Design 2009; 15 (17) . https://dx.doi.org/10.2174/138161209788453176
DOI https://dx.doi.org/10.2174/138161209788453176 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mimetics of the Peptide β-Strand
Mini-Reviews in Medicinal Chemistry Administration of Human Umbilical Cord Blood Cells Produces Interleukin-10 (IL-10) in IL-10 Deficient Mice Without Immunosuppression
Current Stem Cell Research & Therapy Advancements in the Treatment and Repair of Tendon Injuries
Current Tissue Engineering (Discontinued) Vaccine Therapy for Hepatitis B Virus Carrier
Current Drug Targets - Infectious Disorders Novel Peptides: An Alternative Approach for the Treatment of Diabetes Mellitus
Current Drug Therapy New Antihypertensive Drugs Under Development
Current Medicinal Chemistry TGF-Beta Type I Receptor (Alk5) Kinase Inhibitors in Oncology
Current Pharmaceutical Biotechnology Demonstration of Biological and Immunological Equivalence of a Generic Glatiramer Acetate
CNS & Neurological Disorders - Drug Targets Dynamic Expression of MicroRNAs (183, 135a, 125b, 128, 30c and 27a) in the Rat Pilocarpine Model and Temporal Lobe Epilepsy Patients
CNS & Neurological Disorders - Drug Targets Meet Our Editorial Board Member:
Current Pharmaceutical Biotechnology Combination of Anti-EGFR Drugs and Other Molecular Targeted Agents as Anti-Cancer Strategy
Current Cancer Therapy Reviews Use of a Weighted, Automated Analysis of the Differential Blood Count to Differentiate Sepsis from Non-Infectious Systemic Inflammation: The Intensive Care Infection Score (ICIS)
Inflammation & Allergy - Drug Targets (Discontinued) Coagulation and Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets Signaling Pathways Involved in Physiopathology of Pancreatic β -Cells
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Impact of Aging on the Angiogenic Potential of the Myocardium: Implications for Angiogenic Therapies with Emphasis on Sirtuin Agonists
Recent Patents on Cardiovascular Drug Discovery MicroRNAs Determining Inflammation as Novel Biomarkers and Potential Therapeutic Targets
Current Medicinal Chemistry Basic Symptoms and the Prediction of First-Episode Psychosis
Current Pharmaceutical Design Integrase Interactor 1 in Health and Disease
Current Protein & Peptide Science Advances in Nano Drugs for Cancer Chemotherapy
Current Cancer Drug Targets Induction of Strong Anti-HIV Cellular Immunity by a Combination of Clostridium Perfringens Expressing HIV Gag and Virus Like Particles
Current HIV Research